Towards reducing the susceptibility of “high risk” infants to allergic asthma by therapeutic modulation of immunoregulatory functions in the pregnant mother.

通过治疗性调节孕妇的免疫调节功能来降低“高危”婴儿对过敏性哮喘的易感性。

• 批准号: nhmrc : 1047212
• 负责人: Dr Deborah Strickland
• 金额: $ 29.72万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/reducing-susceptibility-high-pregnant-mother/111919
• 关键词: Towards; reducing; susceptibility; risk; infants

This project will deliver information in relation to the potential use and underlying modes of action of a therapeutic agent fed to pregnant mothers at high risk for atopic children, to protect against allergic asthma development in their offspring. Furthermore, the project will address the benefits of this therapeutic agent in relation to protection against inflammation induced preterm birth.

该项目将提供有关治疗剂的潜在用途和基本作用模式的信息，该治疗剂喂给患有特应性儿童高风险的怀孕母亲，以防止其后代发生过敏性哮喘。此外，该项目还将探讨这种治疗剂在预防炎症引起的早产方面的益处。